List of SBIR/STTR awards granted to Stemsynergy Therapeutic

List of SBIR/STTR awards granted to Stemsynergy Therapeutic

List of SBIR/STTR awards granted to Lipella Pharmaceuticals

List of SBIR/STTR awards granted to Lumir Research Institute, Inc.

List of SBIR/STTR awards granted to EXHALIX, LLC

List of Prana Biotechnology Ltd patents

List of companies in JW Asset Management's investment portfolio

where

SBIR/STTR Award Recipient

is

‌

Stemsynergy Therapeutic

	Name	Description	SBIR/STTR Award Recipient	Government Agency	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
	‌ Stemsynergy Therapeutic SBIR Phase I Award, August 2018	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in August, 2018 for $299,994.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Stemsynergy Therapeutic		National Institutes of Health	SBIR	1R43CA217486-01A1	Phase I	299,994	August 1, 2018	sbir.gov/node/1567421
	‌ Stemsynergy Therapeutic SBIR Phase I Award, May 2020	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in May, 2020 for $399,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Stemsynergy Therapeutic		National Institutes of Health	SBIR	1R43CA246945-01A1	Phase I	399,999	May 1, 2020	sbir.gov/node/1912807
	‌ Stemsynergy Therapeutic SBIR Phase I Award, September 2018	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in September, 2018 for $299,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Stemsynergy Therapeutic		National Institutes of Health	SBIR	1R43CA233122-01A1	Phase I	299,999	September 1, 2018	sbir.gov/node/1572371
	‌ Stemsynergy Therapeutic SBIR Phase II Award, September 2021	A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2021 for $945,599.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Stemsynergy Therapeutic		National Institutes of Health	SBIR	1R44CA261490-01A1	Phase II	945,599	September 1, 2021	sbir.gov/node/2190983
	‌ Stemsynergy Therapeutic SBIR Phase II Award, September 2019	A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2019 for $1,375,997.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Stemsynergy Therapeutic		National Institutes of Health	SBIR	4R44CA228840-02	Phase II	1,375,997	September 11, 2019	sbir.gov/node/1687779
	‌ Stemsynergy Therapeutic SBIR Phase I Award, March 2018	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in March, 2018 for $297,882.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Stemsynergy Therapeutic		National Institutes of Health	SBIR	1R44CA228840-01	Phase I	297,882	March 15, 2018	sbir.gov/node/1567439
	‌ Stemsynergy Therapeutic SBIR Phase I Award, April 2022	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in April, 2022 for $399,999.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Stemsynergy Therapeutic		National Institutes of Health	SBIR	1R43CA268456-01A1	Phase I	399,999	April 5, 2022	sbir.gov/node/2338731
	‌ Stemsynergy Therapeutic SBIR Phase I Award, September 2016	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in September, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			SBIR	1R43GM119408-01A1	Phase I	225,000	September 16, 2016	sbir.gov/node/1197353
	‌ Stemsynergy Therapeutic SBIR Phase II Award, September 2017	A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2017 for $2,999,979.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			SBIR	2R44CA144177-04A1	Phase II	2,999,979	September 1, 2017	sbir.gov/node/1323691
	‌ Stemsynergy Therapeutic SBIR Phase II Award, September 2014	A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2014 for $1,499,974.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			SBIR	2R44CA171489-02	Phase II	1,499,974	September 16, 2014	sbir.gov/node/1046139
	‌ Stemsynergy Therapeutic STTR Phase I Award, March 2015	A STTR Phase I contract was awarded to Stemsynergy Therapeutic in March, 2015 for $224,991.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			STTR	1R41CA196011-01A1	Phase I	224,991	March 1, 2015	sbir.gov/node/1162389
	‌ Stemsynergy Therapeutic SBIR Phase I Award, September 2016	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic in September, 2016 for $224,968.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			SBIR	1R43CA200408-01A1	Phase I	224,968	September 5, 2016	sbir.gov/node/1196987
	‌ Stemsynergy Therapeutic STTR Phase I Award, March 2015	A STTR Phase I contract was awarded to Stemsynergy Therapeutic in March, 2015 for $224,991.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			STTR	1R41CA196011-01A1	Phase I	224,991	March 1, 2015	sbir.gov/node/1162389
	‌ Stemsynergy Therapeutic SBIR Phase I Award,	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic for $259,451.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			SBIR	1R43CA171489-01	Phase I	259,451		sbir.gov/node/400070
	‌ Stemsynergy Therapeutic SBIR Phase I Award,	A SBIR Phase I contract was awarded to Stemsynergy Therapeutic for $140,000.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			SBIR	1R43CA144177-01A1	Phase I	140,000		sbir.gov/node/13523
	‌ Stemsynergy Therapeutic SBIR Phase II Award,	A SBIR Phase II contract was awarded to Stemsynergy Therapeutic for $1,999,997.0 USD from the U.S. Department of Health & Human Services.	‌ Stemsynergy Therapeutic			SBIR	2R44CA144177-02	Phase II	1,999,997		sbir.gov/node/389045
	‌ Stemsynergy Therapeutic SBIR Phase II Award, September 2023	A SBIR Phase II contract was awarded to Stemsynergy Therapeutic in September, 2023 for $939,827.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	‌ Stemsynergy Therapeutic		National Institutes of Health	SBIR	2R44CA268456-02	Phase II	939,827	September 22, 2023	sbir.gov/node/2512951

17 results

0 selected

17 results

0 selected